CLDX Stock Analysis Overview
What this means: Celldex Therapeutics (CLDX) gets an Overall Rank of 62, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. CLDX's 62 means that it ranks higher than 62% of stocks.
Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.
CLDX Fundamental Analysis
Upgrade to Premium to unlock Fundamental Ranking
CLDX Short-Term Technical Analysis
Upgrade to Premium to unlock Short-Term Technical Ranking
CLDX Long-Term Technical Analysis
Upgrade to Premium to unlock Long-Term Technical Ranking
CLDX Analyst Ranking
Upgrade to Premium to unlock Analyst Ranking Analysis
CLDX Valuation Ranking Analysis
Upgrade to Premium to unlock Valuation Ranking
CLDX Stock Sentiment Analysis
Upgrade to Premium to unlock Stock Sentiment Ranking
CLDX Stock Analysis Overview
What this means: Celldex Therapeutics (CLDX) gets an Overall Rank of 62, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. CLDX's 62 means that it ranks higher than 62% of stocks.
Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.